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SCD11. Introduction
Obesity is a major cause of debilitating diseases such as type 2 diabe-
tes, hypertension, and cardiovascular disease (Olshansky et al., 2005),
which have a devastating impact on our quality of life and lifespan
(Olshansky et al., 2005). Yet, our search for drugs that prevent and treat
obesity has become one of the most challenging areas in drug discovery.
Glucose and lipids are macromolecules that the body uses as fuel to
regulate energy ﬂuxes andmeet metabolic demands. This fuel is largely
stored in skeletalmuscle and adipose tissues, whosemetabolic commu-
nication determines how the fuel will be selected and used under phys-
iological and pathological conditions (Li et al., 2015; Lu et al., 2014;
Shimizu et al., 2015; Viscarra and Ortiz, 2013). When this communica-
tion is dysregulated, metabolic disorders, including obesity, diabetes,
and metabolic syndrome, often develop (Bilski et al., 2015; Bleau et al.,
2014). While much work has focused on either glucose metabolism in
muscle or lipid metabolism in adipose tissues, we do not know how
communication between these processes maintains metabolic homeo-
stasis in the body.. This is an open access article underMetabolism is regulated by microRNAs. For example, miR-378 and
miR-378*, which are embedded within the ﬁrst intron of the peroxi-
some proliferator-activated receptor γ coactivator 1β (Ppargc1b or
Pgc-1β) gene, are preferentially expressed in metabolically active tis-
sues, skeletal muscle, and brown adipose tissue (BAT) (Carrer et al.,
2012; Eichner et al., 2010). They also critically regulate fatty acidmetab-
olism in mitochondria by targeting carnitine O-acetyltransferase (Crat)
and Mediator 13 (MED13) in liver (Carrer et al., 2012). Hepatic miR-
378 controls liver glucose and lipid homeostasis by modulating insulin
signaling (Liu et al., 2014), and miR-378 stimulates brown-fat expan-
sion by targeting phosphodiesterase 1b (Pde1b) (Pan et al., 2014). Fur-
thermore, miR-378* induces a glycolytic shift by targeting the PGC-1β
partners, ERRγ and GABPA, in breast cancer cells (Eichner et al., 2010),
and levels of miR-378 expression is inversely correlated with the loss
of adipose tissue in cancer cachexia in humans (Kulyte et al., 2014).
Here, we report that miR-378 prevents and treats obesity in mice by
activating the pyruvate-phosphoenolpyruvate (pyruvate-PEP) futile
cycle in the muscle and enhancing lipolysis in adipose tissues. Notably,
we also show that transgenic mice globally overexpressing miR-378
provide a genetic system for investigating the metabolic crosstalk be-
tween different tissues at whole-body levels. Our signiﬁcant ﬁndings
support an unprecedented role of the pyruvate-PEP futile cycle in stim-
ulating lipolysis in adipose tissues to regulate whole-body energy
homeostasis.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Mice and Animal Care
All animal procedures were approved by the Animal Ethics Commit-
tee of Peking UnionMedical College, Beijing (China). Mice were housed
in the animal facility and given free access to water and a standard diet
(SD) of rodent chow or a high-fat diet (HFD) according to the experi-
mental design. miR-378 transgenic (Tg) mice were generated by the
Model Animal Research Center of Nanjing University. Two transgenic
lines were established from two founders identically created with the
same plasmid DNA construct containing miR-378 precursor sequences
and the beta-actin promoter for driving the transgene miR-378 expres-
sion (Figure S1A), and the gender- and age-matched wild-type litter-
mates were served as control group throughout all experiments
presented in the study. C57BL/6 male mice (Vital River Laboratories
Company in Beijing) were used in the experiments treated with
AgomiR-378.
2.2. Metabolic-Chamber Analysis
Metabolic phenotyping of wild-type (Wt, n = 8) and miR-378 Tg
(n = 8) mice on a standard diet was performed using Columbus ×
Oxymax/CLAMS metabolic-chamber analysis at the animal center at
Peking Union Medical College.
2.3. Glucose and Insulin Tolerance Tests
Overnight-fasted mice were given intraperitoneal (i.p.) injections of
glucose (2 mg/g body weight) for the glucose-tolerance test (GTT). For
insulin-tolerance tests (ITT), mice fasted for 4 h and then were given
0.5 mU insulin/g body weight by i.p. injection (Novolin). Blood glucose
was determined with a Lifescan One Touch glucometer.
2.4. Prevention and Treatment of HFD-induced Obesity with AgomiR-378
Cholesterol-modiﬁed AgomiR-378 and control oligos were ordered
from RiboBio (Guangzhou, China). For the prevention study, C57BL/6
mice were fed an HFD, or an SD as control. During HFD feeding,
AgomiR-378 was consecutively administered to the mice weekly by
tail–vein injection (20 μg/g body weight) for 8 weeks. AgomiR-378
and control oligos were administered to 10 male mice, respectively.
For treatment experiments, C57BL/6 mice were fed an HFD for
11 weeks to induce obesity, with mice fed an SD as control. Then,
obese mice were treated weekly with AgomiR-378, or scrambled oligo
as control, by tail–vein injection (20 μg/g bodyweight) for 4 consecutive
weeks. After the last injection, mice underwent GTT and ITT and were
then sacriﬁced for sampling.
2.5. Adenovirus-Mediated Akt1 Rescue Experiments
Constitutively active Akt1, with myristylation-signal sequences
(GSSKSKPKSR) in its N-terminus and a Myc-tag at its C-terminus, was
subcloned from pUSE-myr-Akt1. The recombinant adenoviruses were
packaged byHanhengBiotechnology Corporation (Shanghai, China). Vi-
ruses were administered to miR-378 Tg and Wt mice through tail-vein
injections with 1 × 109 PFU in 0.25 ml PBS. Viruses packaged with
empty vector served as negative control. Injection of the viruses did
not affect food intake in control or treated animals. Micewere sacriﬁced
10 days after the adenovirus injection and sampling.
2.6. C2C12-Cell Culture and Transfection
C2C12-cell culturewas conducted as previously described (Wu et al.,
2015a, 2015b). Brieﬂy, C2C12 cells were cultured in growth medium
consisting of Dulbecco's modiﬁed Eagle's medium (DMEM; Gibco)supplemented with 10% fetal bovine serum (FBS) at 37 °C in a 5% CO2
atmosphere. At 50–60% conﬂuence, cells were switched to differentia-
tion medium (DMEM supplemented with 2% horse serum). C2C12
cells were transfected with miR-378 mimic and control oligos using Li-
pofectamine 2000. Twenty-four h after transfection, cells were lysed
and evaluated for levels of Akt1 protein by Western blotting.
2.7. Adipogenesis In Vitro and Transfection
3T3-L1 cells were obtained from ATCC. Maintenance and adipogen-
esis of 3T3-L1 cells were as described previously using methyl-
isobutylxanthine, dexamethasone, and insulin (MDI) (Hemati et al.,
1997). To induce adipogenesis, cells that were conﬂuent for 2 days
(day 0) were treated with 10% FBS, 1 μM dexamethasone, 0.5 mM
methylisobutylxanthine, 1 μg/ml insulin, and 5 μM troglitazone. On
day 2, cells were fed DMEM containing 1 μg/ml insulin and 10% FBS.
On day 4, cells were refed with DMEM containing 10% FBS and were
transfected with AgomiR-378 or Scd1-overexpression plasmid using Li-
pofectamine 2000. Lipid accumulation in adipocytes was visualized by
staining with Oil Red-O.
2.8. Western-Blot Analysis
Mouse tissues or cells were lysed in lysis buffer containing 50 mM
Tris pH 7.5, 150mMNaCl, 0.5%Nonidet P40, and protease and phospha-
tase inhibitors. Protein lysates were resolved by SDS-PAGE, transferred
to a polyvinylidene ﬂuoride (PVDF) membrane, and immunoblotted
with primary antibodies against total Akt1 (Cell Signaling 2938,
1:1000), phosphorylated Akt1 (Santa Cruz sc7985, 1:2000), total
FoxO1 (Cell Signaling 2880, 1:300), phosphorylated FoxO1 (Cell Signal-
ing 9464s, 1:300), Myc-tag (Millipore 05–724, 1:2000), GAPDH
(Millipore, 1:10,000), or β-actin (Sigma, 1:20,000). Membranes were
washed in TBS washing buffer for 30 min, incubated with horseradish
peroxidase (HRP)–conjugated secondary antibodies (Zhongshanjinqiao
Corporation, 1:2000) for 1 h at room temperature, and washed in TBS
washing buffer for 30min. Eachmembrane was then placed into Detec-
tion Solution (Thermo), incubated for 1 min at room temperature, and
exposed to X-ray ﬁlm.
2.9. Real-Time Quantitative PCR (RT-qPCR) Analysis
Total RNA from mouse tissues or cells was extracted with Trizol re-
agent (Invitrogen). Expression of miR-378 was determined with the
miR-378-speciﬁc TaqMan probe (Applied Biosystems) and the iQ5mul-
ticolor Real-Time PCR Detection System (Bio-Rad). U6 snRNA was used
for normalization. mRNA expression was analyzed with SsoFast
EvaGreen qPCR Master Mix (Bio-Rad) and normalized to GAPDH. All
primers used for RT-qPCR are listed in Table S1.
2.10. Target-Gene Prediction and Luciferase-Reporter Assays
miR-378 targets were predictedwith TargetScan. The wild-type and
mutant forms of 3′-UTRs inmouse Akt1 and Scd1were ampliﬁed by PCR
and cloned into the pGL3-Control vector. HEK-293 cells were co-
transfected with Akt1–3′-UTR or Scd1–3′-UTR and miR-378 mimics.
Empty pGL-3 vectorwas a negative control. A Renilla-luciferase plasmid
was co-transfected with a ﬁreﬂy-luciferase construct as a transfection
control. The results are expressed as ﬁreﬂy-luciferase activity relative
to Renilla-luciferase activity.
2.11. Measurement of DNA Content
DNAcontentwasmeasured andused to evaluate adipocyte numbers
in a given fat depot. To measure genomic DNA content, fat depots were
excised, weighted, and minced. Fat samples with equal amounts were
digested with 10 mM Tris buffer (pH 7.5) containing protease K
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content was calculated as per fat depot.
2.12. Oil Red-O Staining
Cells were ﬁxed with 3.7% (W/V) formaldehyde for 15 min at room
temperature and then stained with 0.3% (W/V) Oil Red-O solution in
60% isopropyl alcohol for 1 h. Excess staining was removed by brieﬂy
washing with water.
2.13. Histology
Adipose-tissue sampleswere ﬁxed in 10% buffered formalin and em-
bedded in parafﬁn forHematoxylin and Eosin (H&E) staining. Cell or nu-
clei numbers per view were quantiﬁed by analyzing randomly selected
ﬁelds fromadipose-tissue sectionsusing the Image Pro Plus 5.1 software
(Olympus). Skeletal muscle samples were immediately frozen with liq-
uid nitrogen-cooled isopentane after dissection and sectioned on a cryo-
stat microtome.α-GPDH and SDH staining was performed as described
(Dunn and Michel, 1997).
2.14. Enzymatic-Activity Assay in Skeletal Muscle
Enzymatic activities of pyruvate dehydrogenase (PDH) were mea-
sured with a pyruvate dehydrogenase kit (Abcam, ab110671) per
manufacturer's instructions. 6-phosphofructokinase (PFK) activities
were examined with a 6-phosphofructokinase kit (Cominbio, NY3)
per manufacturer's instructions. Enzymatic activities of phosphoenol-
pyruvate carboxykinase (PEPCK) were measured with a PEPCK activity
kit (Nanjing Jian Cheng) per manufacturer's instructions.
2.15. Muscle-Homogenates Analysis
Levels of several metabolites in muscle homogenates were mea-
sured with kits assaying pyruvate (Cominbio, NY5), lactate (Nanjing
Jian Cheng, A019-2), acetyl CoA (Cominbio, MY7-1), and the ADP/ATP-
ratio (Sigma, MAK135).
2.16. Serum-Sample Analysis
Measurements of insulin, free-fatty acids (FFA; Senbeijia Corpora-
tion, China), and lactate level in serum (Nanjing Jian Cheng, A019-2)
were performedwith kits permanufacturer's instructions. Insulin levels
in plasma were measured by ELISA (Chrystal Chem).
2.17. Fatty-Acid Analysis
Fatty acids were methylated following the protocol previously de-
scribed (Xu et al., 2010) with few modiﬁcations. Brieﬂy, 10 mg of adi-
pose tissue was homogenized in 500 μL methanol by a tissue-lyser
(QIAGEN TissueLyser II, Germany) at 20 Hz for 90 s. Then, 100 μL tissue
homogenate and 20 μL internal standards (methyl heptadecanoate,
methyl tricosanate, and BHT) were mixed with 1 mL of a methanol–
hexane mixture (4:1, v/v) in a Pyrex tube. The Pyrex tube was cooled
over liquid nitrogen and then added to 100 μL pre-cooled acetyl chlo-
ride. After incubation in thedark at 25 °C for 24 h, sampleswere neutral-
ized with K2CO3 solution and extracted bymixingwith 200 μL hexane 4
times. After evaporation of the resulted supernatant, the extracted
power was redissolved in 100 μL hexane before GC-FID analysis.
Methylated fatty acids were determined on a Shimadzu GC-2010
Plus GC–MS spectrometer (Shimadzu Corporation, Japan) equipped
with a ﬂame-ionization detector (FID), a mass spectrometer, and a
DB-225 capillary–GC column (Agilent technology, USA). Then, 1 μL of
redissolved solution was added through the injection port with a split-
ter (1:60). The temperature in the injection port and FID is 230 °C. Fatty
acids were identiﬁed and quantiﬁed with the standards. The unit ofmicromole fatty acids per liter of plasma is represented as the
mean±standard deviation. Except for directly detected results, saturat-
ed fatty acids (SFAs), unsaturated fatty acids (UFAs), monounsaturated
fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) were also
calculated. In addition,we also calculated ratios that reﬂect the activities
of desaturases, including D5D (C20:4n6/C20:3n6), D6D (C18:3n6/
C18:2n6), SCD16 (C16:1n7/C16:0), and SCD18 (C18:1n9/C18:0).
2.18. Statistical Analysis
Values are presented as means ± s.e.m. The statistical signiﬁcance of
the difference between twomeans was calculated with a Student's t-test
(two-tailed distribution, two-sample unequal variance) and displayed as
p b 0.05 (one asterisk), p b 0.01 (two asterisks), or p b 0.001 (three aster-
isks). The tests were performed using Microsoft Excel, in which the test
type is always set to two-sample equal variance.
3. Results
3.1. miR-378 Transgenic Mice Have Increased Catabolism and Reduced Fat
Mass
To investigate howmiR-378 controls whole-body energy homeosta-
sis in vivo, we generated two lines (C and D lines) of transgenic mice
(Tg) in which the miR-378 transgene was globally overexpressed
under the control of the β-actin promoter (pCAGGS) (Figs. 1A, B, S1A,
and S1B). miR-378 Tgmice had signiﬁcantly reduced bodyweight com-
pared to gender- and age-matched wild type littermates (Figs. 1C, S1C,
S1D, and S1E). They showed the greatest reduction in organ mass in
the muscle, inguinal white adipose tissue (iWAT), and gonadal white
adipose tissue (gWAT) (Fig. 1D, E, and F), but no change in the mass
of other organs (Fig. S1F). Interestingly, we did not observe a change
in the number of adipocytes (Fig. 1G) or the expression of adipogen-
esis marker genes (Fig. 1H), indicating that adipogenesis was not af-
fected in miR-378 mice. However, these mice had smaller adipocytes
in both BAT andWAT, indicating increased lipid catabolism in fat tis-
sues (Fig. 1I and J). They also displayed increased expression of lipid
metabolism genes (Fig. 1K). These ﬁndings suggest that the reduced
fat mass in miR-378 Tg mice is mainly due to reduced adipocyte size
caused by signiﬁcantly increased lipid catabolism rather than re-
duced numbers of adipocytes in adipose tissues. Because our two
lines of miR-378 Tg mice have a similar phenotype, we further char-
acterized only one of our lines in detail.
3.2. miR-378 Tg Mice Display Increased Energy Expenditure
To further validate the enhanced catabolism in adipose tissues of
miR-378 Tg mice, we measured energy inﬂux and consumption in the
whole bodies of both miR-378 Tg and wild-type (Wt) mice with
metabolic-chamber analysis. miR-378 Tg mice had a signiﬁcant overall
increase in body O2 consumption (Figs. 2A and S2A), CO2 production
(Figs. 2B and S2B), and energy expenditure (Figs. 2C and S2C). These re-
sults were correlated with signiﬁcantly increased expression of Ucp1 in
BAT of miR-378 Tg mice (Fig. 2D). Interestingly, these mice consumed
remarkably more food and water than controls (Fig. S2D and S2E).
These data show that miR-378 Tgmice increased their energy expendi-
ture under normal physiological conditions.
Next, we determined the metabolic mechanism underlying the in-
creased energy expenditure in miR-378 Tg mice. First, we found that ex-
pression of lipolytic genes was increased in miR-378 Tg mice (Fig. 2E),
supporting enhanced lipolysis in WAT. We also found increased expres-
sion of genes related to lipid catabolism in both BAT and skeletal muscle
of miR-378 Tg mice (Figs. 2F and S2F). As consequence of the increased
energy expenditure, we observed decreased levels of free fatty acids
(FFA) in serum of miR-378 Tg mice compared to their Wt littermates
(Fig. 2G).
Fig. 1.miR-378 transgenic mice have reduced fat mass and increased catabolism. (A) Representative images of two lines of 6-week-old wild-type (Wt) and miR-378-transgenic (Tg)
female mice fed normal chow. (B) miR-378 overexpression in skeletal muscle (Mus), brown-adipose tissue (BAT), white-adipose tissue (WAT), and liver of Tg mice. (C) Body weight
of Tg and Wt (female) mice fed normal chow at the indicated ages (weeks, w). (D) Weight of muscle groups from 8-week-old Wt and Tg mice (female). tibialis anterior (TA),
gastrocnemius (Gastro), extensor digitorum longus (EDL), quadriceps (Qu). (E) Fat pads from 12-week-old Tg and Wt littermates (female). Inguinal WAT (iWAT), gonadal WAT (gWAT),
and BAT. (F) Relative fat weight of 12-week-old Tg and Wt mice. (G) Genomic DNA content per fat depot. n = 3 female mice at 12-weeks-old per group. (H) Relative mRNA levels of
adipogenic markers in WAT by RT-qPCR. n = 4 female mice at 12-weeks-old. (I) Hematoxylin and eosin (H&E) staining of adipose tissue from 12-week-old female Wt and Tg mice.
Scale bar, 20 μm. (J) Cell number per view (left) of iWAT section presented in (I), and nuclei number per view (right) on BAT section presented in (I). (K) Relative mRNA levels of
adipogenic markers and metabolic regulators in BAT by RT-qPCR. n = 4 female mice at 12-week-old. Data are presented as means ± s.e.m. Statistical analysis was done using
Student's unpaired t-test. *P b 0.05, **P b 0.01, ***P b 0.001. See also Fig. S1.
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We found that these mice had slightly elevated levels of blood glu-
cose when they were fed ad libitum, which signiﬁcantly increasedat a fasting state (Fig. 2H). Consistent with this ﬁnding, miR-378 Tg
mice exhibited normal insulin sensitivity during insulin-tolerance
tests (ITTs) (Fig. 2I), but impaired glucose metabolism in glucose-
Fig. 2.miR-378 Tg mice display increased energy expenditure. (A–C) O2 consumption (A), CO2 production (B), and energy expenditure (C) by metabolic-chamber analysis of Tg andWt
mice. n= 8 12-week-old femalemice for each group. (D) Relative expression (exp) of theUcp1 gene in BAT ofWt and Tgmice. n= 4 12-week-old femalemice. (E) Relative expression of
the lipolytic genes Atgl,Hsl, and Cgi58 inWAT. n=4 12-week-old femalemice. (F) Relative expression of lipolytic (Atgl,Hsl, and Cgi58) and fatty-acid-utilization genes (Lpl, Cd36, Cpt1b) in
BAT. n = 5 12-week-old female mice in each group. (G) Measurement of free-fatty acids (FFA) in serum. n = 5 12-week-old female mice in each group. (H) Blood glucose in Tg andWt
mice fasted for 16 h. n=812-week-old femalemice for each group. (I) Insulin tolerance test (ITT) ofWt (n=6) and Tg (n=5)mice at 12weeks of age. (J) Glucose tolerance test (GTT) of
12-week-oldWt (n=7) and Tg (n=8)mice fasted for 16 h. (K) Insulin levelsweremeasured on 12-week-oldmice fasted for 16 h. n=5 femalemice in each group.Data are presented as
means ± s.e.m. The statistical signiﬁcance of the difference between two means was calculated using Student's unpaired t-test. *P b 0.05, **P b 0.01, ***P b 0.001. See also Fig. S2.
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insulin was similar between miR-378 Tg and Wt mice (Fig. 2K).
These implicate that the hyperglycemia we observed in miR-378 Tg
mice was a result of dysregulated glucose homeostasis rather than
decreased insulin secretion or insulin resistance in peripheral tis-
sues. Furthermore, these data support that the energy deﬁciency
we observed in miR-378 Tg mice is a result of elevated lipolysis and
impaired glucose metabolism.3.3. miR-378 Tg Mice Are Resistant to Obesity When Fed a High-Fat Diet
Next, we tested if miR-378 protects mice against obesity induced by
a high-fat diet (HFD).We found thatmiR-378 Tgmice had a signiﬁcant-
ly lower body weight than Wt mice after 12-weeks on a HFD (Fig. 3A),
even though both lines ate the same amount of food (Fig. 3B). Addition-
ally, miR-378 mice has signiﬁcantly less fat mass than Wt controls
(Fig. 3C), which was supported by a reduced number of adipocytes
Fig. 3.miR-378 Tg mice are resistant to high-fat-diet-induced obesity. (A) Body weight of Wt (n = 7) and Tg (n = 6) mice on high-fat diet (HFD) for 12 weeks (wks). (B) Food intake
measured in Wt and Tg mice fed an HFD and SD, respectively. n = 5 in each group. (C) Percentage of increased fat mass in Wt and Tg mice fed an HFD for 12 weeks relative to
standard diet (SD) (n = 5 in each group). (D) Genomic DNA content per fat depot from Wt and Tg mice fed an HFD for 12 weeks. (E,F) Hematoxylin and eosin (H&E) staining for
adipose tissue fromWt and Tg mice fed an HFD for 12 weeks. Scale bar, 20 μm. (G) Glucose-tolerance test (GTT) in 12-week HFD-fed Wt (n = 5) and Tg (n = 6) mice fasted for 16 h.
Glucose levels were determined at baseline and at the indicated times after an i.p. glucose stimulus (1.5 mg/g body weight). (H) Insulin-tolerance test (ITT) in Wt (n = 5) and Tg
(n = 6) mice fed an HFD for 12 weeks. Data are presented as means ± s.e.m. The statistical signiﬁcance of the difference between two means was calculated with the Student's
unpaired t-test. *P b 0.05, **P b 0.01, ***P b 0.001. NS, statistically non-signiﬁcant.
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Consistent with this ﬁnding, we observed signiﬁcantly improved GTT
and ITT in miR-378 Tg mice on an HFD (Fig. 3G and H).
3.4. Systemically Administering miR-378 Prevents and Ameliorates Obesity
in Mice
We investigated whether systemically administering miR-378
(AgomiR-378) prevents HFD-induced obesity in C57BL/6 mice
(Fig. S3A). We found that simultaneously injecting mice with AgomiR-
378 while they were fed an HFD (Fig. S3B) signiﬁcantly reduced their
body weight (Fig. S3C) and weight gain (Fig. 4A), which was not due
to reduced food intake (Fig. S3D) or lean mass (Fig. S3E). Interestingly,
in AgomiR-378 mice fed an HFD, BAT mass was not reduced (Fig. 4B),
but both iWAT and gWATmass increased signiﬁcantly less than control
mice (Fig. 4B). These results were further supported by a smaller adipo-
cyte size and decreased lipid deposits (Fig. 4C) in AgomiR-378 mice.
Thesemice fedwith HFD also showed improved GTT (Fig. 4D) and near-
ly normal ITT (Fig. 4E).Next, we treatedmice with diet-induced obesity (DIO) by systemat-
ically administrating AgomiR-378 for four weeks (Fig. S4A). At end of
treatment, DIO mice treated with AgomiR-378 had reduced body
weight and weight gain compared to control mice (Fig. S4B and
Fig. 4F). Notably, in AgomiR-378-treated mice, we also found that
WAT mass was remarkably decreased (31%), while BAT mass did not
change comparedwith controlmice (Fig. 4G).We also observed smaller
adipocytes and less lipid deposits in both the BAT andWAT of DIO mice
treatedwith AgomiR-378 (Fig. 4H). AgomiR-378 treatment did not alter
food intake (Fig. S4C) or lean mass (Fig. S4D) in DIO mice; however,
they displayed improved GTT (Fig. 4I) and ITT (Fig. 4J) compared with
their control counterparts.
3.5. The Pyruvate-PEP Futile Cycle in Skeletal Muscle Causes Energy
Deﬁciency in miR-378 Tg Mice
We speculated that the impaired glucose metabolism in miR-378 Tg
micemight be the primary cause of their energy deﬁciency. Interestingly,
we found that miR-378 Tg mice displayed increased expression of key
Fig. 4. Systematic administration of miR-378 prevents and ameliorates obesity in mice. (A–E) C57BL/6 mice fed a high-fat diet (HFD) or standard diet (SD) as control for 10 weeks. During HFD
feeding, cholesterol modiﬁed AgomiR-378 (HFD-378) was administered (20 μg/g body weight) weekly for 8 consecutive weeks, which signiﬁcantly prevented HFD-induced obesity (DIO)
compared to control oligos (HFD-Con). n = 10 male mice in each group. (A) Reduced body-weight gain. (B) Reduced white-fat mass. (C) Reduced size of adipocytes and lipid droplets by
Hematoxylin and Eosin staining (H&E). Scale bar, 20 μm. (D) Improved glucose-tolerance test (GTT). (E) Corrected insulin-tolerance test (ITT). (F–J) C57BL/6 mice were fed an HFD for 11 weeks
to induce obesity (DIO). DIO mice were treated weekly with AgomiR-378 (HFD-378) or control oligos (HFD-Con) for 4 consecutive weeks. AgomiR-378 treatment (20 μg/g body weight)
signiﬁcantly ameliorates HFD-induced obesity compared to controls (HFD-Con). n = 10 male mice in each group. (F) Reduced body-weight gain. (G) Reduced white-fat mass. (H) Reduced size
of adipocytes and lipid droplets from Hematoxylin and Eosin (H&E) staining. Scale bar, 20 μm. (I) Improved GTT. (J) Corrected ITT. Data are presented as means ± s.e.m. The statistical
signiﬁcance of the difference between two means was calculated using Student's unpaired t-test. *P b 0.05, **P b 0.01, ***P b 0.001. NS, statistically non-signiﬁcant. See also Figs. S3 and S4.
99Y. Zhang et al. / EBioMedicine 5 (2016) 93–104glycolytic genes (Fig. 5A) and enhanced activity of α-glycerophosphate
dehydrogenase (α-GPDH) in their muscle tissues (Fig. 5B), indicating
that they had signiﬁcantly enhanced glycolytic activities. However, we
did not detect differences in the levels of lactate in either their serum(Fig. S5A) or skeletal muscle (Fig. S5B). Consistent with these ﬁndings,
mRNA levels of lactate dehydrogenase (Ldh) in muscle was not different
between miR-378 Tg and Wt mice (Fig. S5C). Surprisingly, we detected
lower levels of pyruvate in the muscle of miR-378 Tg mice than Wt
Fig. 5. The pyruvate-PEP futile cycle in skeletal muscle causes energy deﬁciency in miR-378 Tg mice. (A) Relative expression (exp) of the key glycolytic genes hexokinase 2 (Hk2),
phosphofructokinase 1 (Pfk1), and pyruvate kinase (Pk) in skeletal muscle of Wt and Tg mice. (B) Enzymatic staining of α-glycerophosphate dehydrogenase (α-GPDH) and succinate
dehydrogenase (SDH), which are enriched in glycolytic and oxidative myoﬁbers, respectively, in gastrocnemiusmuscle of Wt and Tg mice. Images are representative of three mice in
each group. Scale bar, 20 μm. (C,D) Pyruvate level (C) and pyruvate dehydrogenase (PDH) activities (D) in gastrocnemius muscle homogenates of Wt and Tg mice. (E) Relative
expression of the gluconeogenesis genes pyruvate carboxlase (Pc) and phosphoenolpyruvate carboxykinase (Pepck) in skeletal muscle of Wt and Tg mice. (F) Enzymatic activity of
PFK1 and PEPCK in gastrocnemius muscle homogenates of Wt and Tg mice. (G) Acetyl-CoA level in gastrocnemius muscle homogenates of Wt and Tg mice. (H) ATP/ADP ratio in
gastrocnemiusmuscle homogenates of Wt and Tg mice. (I) Relative expression of the Pepck gene in gastrocnemiusmuscle of Wt and Tg mice fed an HFD for 8 weeks, respectively. n =
5 male mice in each group. Data are presented as means ± s.e.m. The statistical signiﬁcance of the difference between two means was calculated using Student's unpaired t-test.
*P b 0.05, **P b 0.01. See also Fig. S5.
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vate dehydrogenase (PDH) (Fig. 5D), which converts pyruvate to acetyl-
CoA.
Biochemically, a futile cycle occurs when two metabolic pathways
run simultaneously in opposite directions, thereby not causing an effect
other than to dissipate energy in the form of heat (Schwender et al.,
2004). Because increased glycolytic activity did not elevate pyruvate
in the muscle tissues of miR-378 Tg mice, we reasoned that pyruvate
was converted back to phosphoenolpyruvate (PEP) by a reverse reac-
tion in the pyruvate-PEP futile cycle (Boiteux and Hess, 1981), which
is catalyzed by pyruvate carboxlase (PC) and phosphoenolpyruvate
carboxykinase (PEPCK). Indeed, we observed signiﬁcantly increased
levels of mRNA (Fig. 5E) and enzymatic activity (Fig. 5F) of PC and
PEPCK in the muscle of miR-378 Tg mice compared with Wt controls.
We also found that these tissues displayed remarkably decreased levels
of acetyl-CoA (Fig. 5G) andATP (Fig. 5H). Notably, feeding thesemice an
HFD restored Pepck expression to levels similar to that of Wt mice fed astandard diet (SD) (Fig. 5I), indicating that the pyruvate-PEP futile cycle
was attenuatedwhenmiR-378 Tgmicewere provided sufﬁcient energy
with an HFD (Fig. 5I). These data implicate that miR-378 activates the
pyruvate-PEP futile cycle in skeletal muscle to at least partially cause
the energy deﬁciency seen inmiR-378 Tgmice under normal physiolog-
ical conditions. This implication may explain why miR-378 Tg mice re-
sist HFD-induced obesity (Fig. 3).
3.6. miR-378 Activates the Pyruvate-PEP Futile Cycle via the
Akt1-FoxO1-PEPCK Pathway
Next, we investigated the molecular mechanism behind how miR-
378 activates the pyruvate-PEP futile cycle in the muscle of miR-378
Tgmice. To identify its target, we ﬁrst assessed the expression of report-
ed miR-378 targets (Carrer et al., 2012; Eichner et al., 2010; Pan et al.,
2014; Ruckerl et al., 2012) (i.e., Pde1b, Pde3b, Crat, Med13, Errγ, and
Akt1) (Fig. S6A) and found that only Akt1 expression was signiﬁcantly
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mice (Fig. 6A). To learn howmiR-378 and Akt1 work together to regu-
late the pyruvate-PEP futile cycle in these mice, we sought an Akt1-
regulated substrate. Interestingly, the transcription factor FoxO1 is a di-
rect substrate of Akt1 (Biggs et al., 1999; Nakae et al., 2001; Rena et al.,
1999), and FoxO1 transcriptionally regulates Pepck, the key rate-
limiting enzyme in the pyruvate-PEP futile cycle (Puigserver et al.,
2003). Therefore, we speculated that miR-378 activates the pyruvate-
PEP futile cycle by targeting the Akt1-FoxO1-PEPCK pathway. Indeed,
we found an increase in the hypophosphorylated (active) form of
FoxO1 in the muscle of miR-378 Tg mice. Total FoxO1 protein levels
were not overtly different between miR-378 Tg and Wt mice (Fig. 6A).
To conﬁrm that miR-378 activates the pyruvate-PEP futile cycle by
targeting the Akt1-FoxO1-PEPCK pathway, we restored the protein
levels of Akt1 in miR-378 Tg mice with adenovirus containing a form
of Akt without the miR-378-targeting sequence in its 3′-UTR (Ad-
CaAkt) (Figs. S6D and S6E). This adenovirus restored protein expression
of both total Akt and p-Akt in the muscle of miR-378 Tg mice to levelsFig. 6.miR-378 activates pyruvate-PEP futile cycle via the Akt1-FoxO1-PEPCK pathway. (A) Phos
determined byWestern blot. GAPDH served as loading control. (B) Adenovirus containing constitu
Scramble adenovirus served as control (Con). Tendays after infection, antibodies detected express
muscle byWestern blot. β-actin served as loading control. (C) Relative expression of the Pepck ge
genes inWAT, BAT, and skeletal muscle of mice described in (B). (G) Free-fatty acids (FFA) in seru
group. The statistical signiﬁcance of the difference between two means was calculated using Studcomparable to Wt mice (Fig. 6B). Moreover, the phosphorylated form
of FoxO1 was expressed at similar levels in the muscle of miR-378 Tg
and Wt mice (Fig. 6B). Furthermore, restoring Akt1 rescued Pepck ex-
pression in the muscle of miR-378 Tg mice to the levels comparable to
Wt mice (Fig. 6C).
More signiﬁcantly, inmiR-378 Tgmice, restoring Akt1 attenuated li-
polysis in WAT (Fig. 6D) and fatty acid use in both BAT (Fig. 6E) and
muscle (Fig. 6F). It also restored FFA levels in serum of miR-378 Tg
mice (Fig. 6G). Thus, activation of the pyruvate-PEP futile cycle in the
muscle is the primary cause for elevated lipolysis in adipose tissues of
the miR-378 Tg mice.
3.7. miR-378 Stimulates Lipolysis in WAT by Targeting Scd1
We then examined what miR-378 might target in adipose tissue to
promote lipolysis. Interestingly, expression of all the known miR-378
targets, including Akt1, remained unchanged in both BAT and WAT of
miR-378 Tg mice (Figs. S6F and S6G). We then searched for additionalphorylated (p-) and total (t-) level of Akt1 and FoxO1 in skeletal muscle of Wt and Tg mice
tively active Akt1 (Myc-taggedMyr-Akt1)was injected into the tail-vein ofWt and Tgmice.
ion ofMyc-taggedMyr-Akt1 andphosphorylated (p-) and total (t-) levels of FoxO1 in skeletal
ne in gastrocnemiusmuscle of Wt and Tgmice described in (B). (D–F) Expression of lipolytic
m of mice described in (B). Data are presented as means± s.e.m. from 5male mice in each
ent's unpaired t-test. *P b 0.05. NS, statistically non-signiﬁcant. See also Fig. S6.
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that the mRNA of stearoyl-CoA desaturase 1 (Scd1) contains a miR-
378 binding site in its 3′-UTR (Fig. 7A). Scd1 catalyzes the production
ofmonounsaturated fatty acids to regulate lipid partitioning between li-
pogenesis and oxidation (Ntambi, 1995, 1999). Interestingly, Scd1-
knockout (Scd1−/−) mice display a similar phenotype to that of miR-
378 Tg mice, including a lean body type and resistance to obesity
(Cohen et al., 2002; Miyazaki et al., 2001; Ntambi et al., 2002). We
ﬁrst validated that Scd1 is a target of miR-378 in HEK-293 cells with
luciferase-reporter assays (Fig. 7B). Then we evaluated its expression
in adipocytes and found that endogenous Scd1 was reduced in adipo-
cytes overexpressing miR-378 (Fig. 7C). Interestingly, we also found
that overexpressing miR-378 upregulated lipolytic genes in adipocytes
(Fig. 7D). Consistent with our in vitro data, we observed reduced Scd1
expression (Fig. 7E) and decreased Scd1 activity by measuring cellular
fatty-acid ratios (C16:1/C16:0 and C18:1/C18:0) in both BAT and WAT
of miR-378 Tg mice (Fig. 7F and G). Furthermore, we observed reduced
Scd1 expression in both BAT and WAT of C57BL/6 mice treated withFig. 7.miR-378 stimulates lipolysis inWAT by targeting Scd1. (A) Alignment of miR-378-target
was based on themouse Refseq (NM_009127). Indicated formof UTR (m-utr)wasmutated from
luciferase activity inHEK293 cells expressing thewild-type (wt-utr) ormutated 3′-UTR (m-utr)
independent measurements. (C) Expression (exp) of Scd1 decreased in 3T3-L1-induced a
experiments. (D) Expression of the lipolytic genes Hsl and Atgl in 3T3-L1-induced adipocytes
and Wt (n= 5) mice. (F,G) Decreased SCD1 enzymatic activities in BAT and WAT tissues of Tg
expression of Scd1 in BAT (left) and WAT (right) tissues of AgomiR-378 treated DIO mice (n
between two means was calculated using Student's unpaired t-test. *P b 0.05.AgomiR-378 and fed an HFD (Fig. 7H). Together, these data support
that miR-378 promotes lipolysis in adipose tissues by targeting Scd1
both in vitro and in vivo.
4. Discussion
In this report, we not only uncover the pharmacological function of
miR-378 in preventing and treating obesity, but we also unravel a
unique function of miR-378 in regulatingmetabolic communication be-
tween the muscle and adipose tissues to control energy homeostasis at
whole-body levels. miR-378 activates the pyruvate-PEP futile cycle by
targeting the Akt1-FoxO1-PEPCK pathway in the muscle, which then
enhances lipolysis viamiR-378 targeting Scd1 in adipose tissues. Impor-
tantly, we demonstrate that miR-378 activates the pyruvate-PEP futile
cycle in skeletal muscle to control whole-body energy homeostasis in
mice.
Glycolysis is a metabolic pathway in which glucose is converted to
pyruvate to generate two molecules of ATP per molecule of glucose.sequence in the Scd1 3′-UTR predicted with TargetScan. The nucleotide coordinate of Scd1
the seedmatches. (B) Effect ofmiR-378 or a non-speciﬁc-control oligonucleotide (NC) on
of Scd1. Empty pGL-3 vector served as negative control. Values aremeans± s.e.m. of three
dipocytes transfected with miR-378. Values are means ± s.e.m. of three independent
described in (C). (E) Reduced expression of Scd1 in BAT tissues of miR-378 Tg (n = 5)
mice evidenced by reduced ratios of (F) C16:1/C16:0 and (G) C18:1/C18:0. (H) Reduced
= 6). Data are presented as means ± s.e.m. The statistical signiﬁcance of the difference
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which two metabolic pathways run simultaneously in opposite direc-
tions without an overall effect other than to dissipate energy in the
formof heat. In general, futile cycles have been regarded as energetically
wasteful reactions that must be avoided in metabolic pathways under
normal physiological conditions. However, researchers have speculated
that futile cycles may uniquely regulate metabolism to maintain energy
homeostasis, especiallywhen energy is rapidly needed (Munakata et al.,
2012; Orman et al., 2012; Tolla et al., 2015); although, they have yet to
provide data that supports this speculation. In this report, we demon-
strated that the miR-378-Akt-FoxO1-PEPCK pathway mediates the
pyruvate-PEP futile cycle. Speciﬁcally, in miR-378 Tg mice, we found
that pyruvate from glycolysis cannot enter the Krebs cycle to produce
energy. Instead, it is converted back to PEP in a gluconeogenesis reaction
mediated by PEPCK and PC, which costs an ATP molecule and produces
an energy deﬁciency. As a consequence of this futile cycle, more energy
from lipolysis is needed to balance energy homeostasis, which is sup-
ported by our observation that miR-378 Tg mice have signiﬁcantly en-
hanced lipolysis in their adipose tissues. These results suggest that
miR-378 activates the pyruvate-PEP futile cycle to orchestrate the glu-
cose–lipid metabolic crosstalk between the muscle and adipose tissues
and maintain energy homeostasis. One implication of this ﬁnding is
that any dysregulated futile cycles of either glucose or fatty acids may
be the primary cause of metabolic disorders in humans. Thus, the
miR-378-mediated pyruvate-PEP futile cycle or other metabolic futile
cycles may serve as promising targets for developing therapies against
obesity and/or other metabolic diseases.
We also revealed that Scd1 is a functional target ofmiR-378 that pro-
motes lipolysis in adipose tissues of miR-378 Tg mice. SCD1 critically
regulates lipid metabolism, and dysregulation of SCD1 activity results
in various metabolic disorders, including diabetes, cardiovascular dis-
ease, and obesity (Dobrzyn et al., 2015; Sampath and Ntambi, 2011,
2014; Stamatikos and Paton, 2013). Similar to our miR-378 Tg mice,
Scd1-knockout mice are also resistant to HFD-induced obesity (Cohen
et al., 2002; Ntambi et al., 2002). Therefore, inmiR-378 Tgmice, we pro-
pose a model in which miR-378 activates the Akt1-FoxO1-PEPCK path-
way in skeletal muscle to induce the pyruvate-PEP futile cycle, which
impairs glucose metabolism and causes energy deﬁciency. Then, at the
same time in adipose tissues, miR-378 directly targets Scd1 to enhance
lipolysis (Fig. S7). Because of miR-378 induced glucose futile cycle, the
Tg mice utilize fatty acids to meet energy demand. As a consequence,
FFA in the circulation gets low despite of elevated lipolysis in adipose
tissues. To validate the primary effect of miR-378-targeted Akt-FoxO1-
PEPCK, we used constitutively active Akt1 (ca-Akt1) to rescue the met-
abolic phenotype of miR-378 Tg mice and observed signiﬁcantly atten-
uated lipolysis in ca-Akt1 treated Tg mice. These ﬁndings suggest that
miR-378 mediates the metabolic communication between muscle and
fat by targeting Akt1 and Scd1 to regulate systemic energy homeostasis.
It would be very intriguing to identify signals or molecules in medi-
ating the metabolic communications between muscle and fat tissues in
miR-378 transgenic mice. Previous publications demonstrate that some
metabolites may mediate the regulation of the whole body metabolic
homeostasis. For example, insufﬁcient alanine supply mediates a
muscle-liver-fat signaling by upregulating FGF21 expression in liver
(Shimizu et al., 2015). We observed signiﬁcantly lower level of pyru-
vate, lactate, actyl-CoA and FFA in Tg mice than those in wild type con-
trol. All of those metabolites are indicators for energy supply, thus the
data indicating miR-378 Tg mice suffer severe energy insufﬁciency.
Identiﬁcations of themolecules or signalswhich convey such energy de-
ﬁciency and mediate inter-organ crosstalk will help us to understand
the mechanism of miR-378 in maintaining whole body metabolic
homeostasis.
Clinically, our ﬁndings support a critical role for miR-378 in human
metabolic disorders. Similarly, Kulyté A et al. recently reported that
miR-378 was signiﬁcantly upregulated in cachectic cancer patients,
and its expression was strongly and positively associated withcatecholamine-stimulated lipolysis in human adipocytes (Kulyte et al.,
2014). Their ﬁndings suggest that increased miR-378 expression could
be an etiological factor in the disease-associated loss of adipose tissue
by affecting adipocyte lipolysis and inhibiting disease-induced upregu-
lation of miR-378. Thus, miR-378 may represent a promising target for
ameliorating the severity of human diseases caused by impaired lipid
metabolism.
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